VEGF ANALOGS AND METHODS OF USE

摘要

Modified VEGF proteins that inhibit VEGF-mediated activation or proliferation of endothelial cells are disclosed. The analogs may be used to inhibit VEGF-mediated activation of endothelial cells in angiogenesis-associated diseases such as cancer, infilammatory diseases, eye diseases, and skin disorders.